These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34696688)

  • 21. Sgk1-dependent stimulation of cardiac Na+/H+ exchanger Nhe1 by dexamethasone.
    Voelkl J; Pasham V; Ahmed MS; Walker B; Szteyn K; Kuhl D; Metzler B; Alesutan I; Lang F
    Cell Physiol Biochem; 2013; 32(1):25-38. PubMed ID: 23860121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlling cell proliferation by targeting cyclin-dependent kinase 6 using drug repurposing approach.
    Madhana Priya N; Balasundaram A; Sidharth Kumar N; Udhaya Kumar S; Thirumal Kumar D; Magesh R; Zayed H; George Priya Doss C
    Adv Protein Chem Struct Biol; 2023; 135():97-124. PubMed ID: 37061342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based virtual screening, molecular docking, molecular dynamics simulation and MM/PBSA calculations towards identification of steroidal and non-steroidal selective glucocorticoid receptor modulators.
    Zare F; Solhjoo A; Sadeghpour H; Sakhteman A; Dehshahri A
    J Biomol Struct Dyn; 2023; 41(16):7640-7650. PubMed ID: 36134594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of human tau-tubulin kinase 1 inhibitors: an integrated e-pharmacophore-based virtual screening and molecular dynamics simulation.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2020 Feb; 38(3):886-900. PubMed ID: 30829560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of
    Joshi T; Joshi T; Sharma P; Chandra S; Pande V
    J Biomol Struct Dyn; 2021 Feb; 39(3):823-840. PubMed ID: 31965918
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Kinetic Characterization of Serum- and Glucocorticoid-Regulated Kinase Inhibitors Using a Fluorescence Polarization-Based Assay.
    Kim J; Kim D; Jung H; Lee J; Hong VS
    SLAS Discov; 2021 Jun; 26(5):655-662. PubMed ID: 33783250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Deleterious Mutations on Structure, Function and Stability of Serum/Glucocorticoid Regulated Kinase 1: A Gene to Diseases Correlation.
    AlAjmi MF; Khan S; Choudhury A; Mohammad T; Noor S; Hussain A; Lu W; Eapen MS; Chimankar V; Hansbro PM; Sohal SS; Elasbali AM; Hassan MI
    Front Mol Biosci; 2021; 8():780284. PubMed ID: 34805284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LEFTYA Activates the Epithelial Na+ Channel (ENaC) in Endometrial Cells via Serum and Glucocorticoid Inducible Kinase SGK1.
    Salker MS; Hosseinzadeh Z; Alowayed N; Zeng N; Umbach AT; Webster Z; Singh Y; Brosens JJ; Lang F
    Cell Physiol Biochem; 2016; 39(4):1295-306. PubMed ID: 27606670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of
    Chandel S; Singh R; Gautam A; Ravichandiran V
    J Biomol Struct Dyn; 2022; 40(23):12827-12840. PubMed ID: 34569452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [SGK1 as a therapeutic target for central nervous system diseases].
    Xing YK; Luo W; Fan MY; Tan YW; Li X
    Sheng Li Xue Bao; 2023 Jun; 75(3):451-464. PubMed ID: 37340653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies.
    Gálvez J; Polo S; Insuasty B; Gutiérrez M; Cáceres D; Alzate-Morales JH; De-la-Torre P; Quiroga J
    Comput Biol Chem; 2018 Jun; 74():218-229. PubMed ID: 29655025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and γ-ray irradiation was elucidated.
    Tang Z; Shen Q; Xie H; Zhou Z; Shi G; Zhang C; Mohammed A; Wu Y; Ni S; Zhou X
    Oncol Rep; 2018 Mar; 39(3):1505-1515. PubMed ID: 29328462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
    Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
    Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of HDAC8-ligands' intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents.
    Dewaker V; Srivastava AK; Arora A; Prabhakar YS
    J Biomol Struct Dyn; 2021 Aug; 39(13):4726-4751. PubMed ID: 32578494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors.
    Jang H; Park Y; Jang J
    Front Pharmacol; 2022; 13():1036844. PubMed ID: 36457711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel potential inhibitor of thymidylate kinase from Variola virus.
    Sinha P; Yadav AK
    J Biomol Struct Dyn; 2023; 41(23):14092-14102. PubMed ID: 36907647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant derived active compounds as potential anti SARS-CoV-2 agents: an
    Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC
    J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of potential selective inhibitors for ROCKI and ROCKII isoforms with molecular modeling techniques: structure based docking, ADMET and molecular dynamics simulation.
    Bayel Secinti B; Tatar G; Taskin Tok T
    J Biomol Struct Dyn; 2019 Jun; 37(9):2457-2463. PubMed ID: 30047850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.